On January 10, 2026, a crucial update emerged for clinical professionals and regulatory teams concerning an investigative approach to chronic pelvic pain (CPP) in women. A new clinical study aims to evaluate a combination of Pain Neuroscience Education (PNE) and Basic Body Awareness Therapy (BBAT) alongside standard physiotherapy practices. The trial, spearheaded by Sena Öndeş and Istinye University, has not yet begun recruitment but is expected to bring valuable insights into the management of CPP.
What changed?
The upcoming study focuses on CPP, a multifaceted condition affecting women globally. Its etiology and treatment remain complex, often requiring multidisciplinary care. This research initiative introduces innovative behavioral strategies, including PNE and BBAT, integrated into current physiotherapy protocols. These methods emphasize education about pain mechanisms and physical awareness exercises aimed at improving patient outcomes. As of now, the trial is marked “not yet recruiting.”
What are the study objectives?
The study’s primary aim is to assess the effectiveness of combining PNE and BBAT with standard physiotherapy approaches in managing CPP among female patients. PNE seeks to reshape a patient’s understanding of pain by highlighting its neurological underpinnings, while BBAT focuses on developing body awareness through movement exercises. Together, these interventions hope to address both the physiological and psychological aspects of CPP. The trial will monitor patient outcomes to establish the viability and safety of these approaches in routine care.
What should professionals know?
The trial is sponsored by Istinye University and clinical investigator Sena Öndeş. It emphasizes the need for regulatory insights into alternative, non-invasive treatments for chronic conditions. Clinical teams and regulatory professionals monitoring innovative pain management techniques should watch this study closely for potential implications on future guidelines and routine care protocols.
It is crucial to note that the integration of behavioral therapies into standard physiotherapy showcases a growing trend toward holistic and patient-centered approaches in managing chronic pain. Regulatory approvals will depend on the trial outcomes demonstrating measurable benefits and demonstrating compliance with safety standards.
FAQ
1. When does the trial start?
The trial is currently listed as “not yet recruiting.” Further updates on the recruitment timeline are expected.
2. What is Pain Neuroscience Education?
Pain Neuroscience Education (PNE) educates patients on the neurological mechanisms behind pain, aiming to reduce pain-related fear and improve coping strategies.
3. How can Basic Body Awareness Therapy benefit patients?
BBAT focuses on improving body awareness through structured movement and breathing exercises, potentially enhancing physical and emotional well-being.
4. Who can participate?
The study targets women diagnosed with Chronic Pelvic Pain Syndrome. Specific inclusion/exclusion criteria will be published during the recruitment phase.
Conclusion
This clinical trial represents a significant step toward innovative and holistic care strategies for chronic pelvic pain. Professionals should monitor developments closely, as findings could inform future guidelines and treatment protocols. Participation and regulatory evaluations will frame the broader implications of integrating these behavioral therapies into standard care.
Disclaimer
This article is for informational purposes only and does not constitute legal, medical, or clinical advice. Professionals should consult relevant authorities and guidelines for specific regulatory requirements.
Full announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07328672?term=medical+device